A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
PIRC aims to assist partners with innovation and to optimize healthcare and its delivery through research and collaborative efforts.
This collaborative aims to investigate outcomes of mothers and babies individually and together, identify social determinants of health and uncover strategies to reduce racial, ethnic...
There is an urgent need to understand the clinical and economic consequences associated with AKI in hospitalized patients with COVID-19 to better inform treatment decisions...
Today’s successful Quality team needs a comprehensive solution to ensure clinical quality improvement in their hospital. We've got five core capabilities to look for.
Persistent severe AKI in hospitalized patients can cause adverse outcomes, clinicians are working to identify risks and provide intervention to improve outcomes and reduce costs.
The SARS-Cov-2 delta variant has filled U.S. hospitals to capacity reinforcing the need for data to better understand disease severity and support evidence-based treatment decisions...
Therapeutic Landscape for Treatment of HER2+ mBC Continues to Evolve.
Premier Applied Sciences and Meitheal Pharmaceuticals collaborate to study anticoagulant use in COVID-19 patients.
Charlotte Business Journal | Michael J. Alkire, CEO at Premier, said the PINC AI brand will highlight how the firm is accelerating its innovation.
RamaOnHealthcare | Mike shares his thoughts about the next frontier in healthcare, including Premier's recently launched PINC AI™ platform.
The healthcare technology market today is flooded with ideas but creating meaningful and sustainable change is complex.
Forbes | A new study conducted via the U.S. Premier Healthcare Database revealed nearly one in every four Covid-19 deaths may be attributed to hospital strain.